Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.8769
-0.0183 (-2.04%)
At close: Oct 9, 2026, 4:00 PM EDT
0.8860
+0.0091 (1.04%)
After-hours: Oct 9, 2026, 7:49 PM EDT
Cognition Therapeutics Employees
Cognition Therapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 14 or -50.00% compared to the previous year. That makes Cognition Therapeutics the 39,270th largest employer in the world and 5,776th in the United States.
Employees
14
Change (1Y)
-14
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,198,214
Market Cap
83.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | -14 | -50.00% | 14 | 0 |
| Dec 31, 2024 | 28 | 0 | - | 25 | 3 |
| Dec 31, 2023 | 28 | 3 | 12.00% | 25 | 3 |
| Dec 31, 2022 | 25 | 4 | 19.05% | 22 | 3 |
| Dec 31, 2021 | 21 | 1 | 5.00% | 19 | 2 |
| Sep 30, 2021 | 18 | -2 | -10.00% | 15 | 3 |
| Jun 30, 2021 | 22 | - | - | 18 | 4 |
| Mar 31, 2021 | 22 | - | - | 20 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Acrivon Therapeutics | 76 |
| ImmuCell | 73 |
| Cardiff Oncology | 31 |
| NeurAxis | 24 |
| PDS Biotechnology | 21 |
| Equillium | 15 |
| Nutriband | 13 |
| ProMIS Neurosciences | 11 |
CGTX News
- 10 days ago - Cognition Therapeutics schedules Type C meeting with FDA for trial of CT1812 - TheFly
- 10 days ago - Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB - GlobeNewsWire
- 4 weeks ago - Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 2 months ago - Cognition Therapeutics reports Q2 EPS (4c), consensus (6c) - TheFly
- 2 months ago - Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update - GlobeNewsWire
- 2 months ago - Cognition Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Cognition Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Cognition Therapeutics Slides: Investor presentation - Filings